drugset
drugset / Trial / NCT06699628

Phase I Trial Evaluating the Pharmacokinetics of Single Ascending Oral Doses of IRL757 in Healthy Elderly Volunteers

NCT06699628 ↗

Phase 1 Completed 12 enrolled Integrative Research Laboratories AB
NaParallel-groupOpen-labelTreatment

Summary

This is a phase I trial evaluating the pharmacokinetics of single ascending oral doses of IRL757 in healthy elderly volunteers.

Timeline

Start
2024-09-23
Primary completion
2024-11-11
Completion
2024-11-11

Drugs

EvaluationDrugModalityDoseRoute
Subject IRL757 Unknown — Oral

Indications

No indication recorded.